The Precision BioLogic Inc. and the Affinity Biologicals, Inc. research team presented a poster comparing chromogenic versus clot-based factor VIII assays measuring pegylated factor VIII therapeutic concentrate at
Posts
Aug 19, 2021 4:57pm
0 Comments
Aug 19, 2021 4:52pm
At
the July 17–21, 2021 meeting of the International Society on Thrombosis and Haemostasis, the Precision BioLogic Inc. and the Affinity Biologicals, Inc. research team presented a poster that demonstrates how inactivated factor VIII reagent preparations that are employed for factor VIII activity assays and inhibitor assays may contain factor VIII that is detectable by immunoassay, albeit physiologically inactive.
0 Comments
Aug 19, 2021 4:29pm
The Precision BioLogic Inc. and the Affinity Biologicals, Inc. research team presented a poster describing their factor VIII antigen immunoassay recovery of various therapeutic concentrates at
the July 17–21, 2021 meeting of the International Society on Thrombosis and Haemostasis.
0 Comments
Aug 6, 2021 9:28am
From Crystal Wilson: Hello George, I am writing to ask if you could help me to understand how, on rare occasions, patients suffering from bleeding disorders such as von Willebrand disease or hemophilia have suffered from hypercoagulable episodes such as pulmonary emboli or deep vein thrombosis. Thanks.
1 Comment
